心血管リスク予測のための統合されたハイブリッドモデル:統計的,カーネルベースの,およびニューラルアプローチの融合
Mudassir Khan1, Rupali A Mahajan2, Nithya Rekha Sivakumar3
1Department of Computer Science, College of Computer Science, Applied College Tanumah, King Khalid University, Abha, Saudi Arabia.
Journal of cellular and molecular medicine
|August 28, 2025
まとめ
新しいハイブリッド・マシン・ラーニング・アプローチ (HMLCRP) は,ロジスティック・リグレッション,サポート・ベクトル・マシン,ニューラル・ネットワークを組み合わせることで,より正確で信頼できる結果を得ることで,心血管疾患のリスク予測を改善します.
科学分野:
- 心臓病科
- 機械学習
- 予測分析
背景:
- 心血管疾患 (CVD) は,依然として世界の主要な死因です.
- 従来の機械学習モデルでは 心血管疾患のリスク因子と疾患の発症の複雑な関係を正確に捉えることが困難です
- 心血管リスクの正確な予測は 効果的な予防と管理戦略に不可欠です
研究 の 目的:
- 心血管リスク予測のための新しいハイブリッド・マシン・ラーニング (HMLCRP) の導入と評価.
- 多様な機械学習アルゴリズムを統合することにより,CVDリスク評価の正確性と信頼性を高める.
- 心血管疾患のリスク要因を特定し,予測モデルを改良する.
主な方法:
- ロジスティック回帰 (LR),サポートベクトルマシン (SVM),ニューラルネットワーク (NN) を組み合わせたハイブリッドマシンラーニングアプローチ (HMLCRP) を開発した.
- 血圧,家族歴,ストレス,年齢,性別,コレステロール,BMI,ライフスタイルの選択
- HMLCRPモデルをトレーニングし,ベンチマークデータセット:心臓統計,心臓病,フレミングハム心臓研究データセットを使用して検証しました.
主要な成果:
- HMLCRPは個々の機械学習モデルと比較して優れた予測性能を示した.
- 正確さ,精度,リコール,F1スコアなどの評価指標はモデルの有効性を確認しました.
- ハイブリッドアプローチは,LR,SVM,NNの強みを活用して,堅実な分類とリスク予測を実現しました.
結論:
- HMLCRPは,心血管リスク管理のためのパーソナライズドヘルスケアの重要な進歩を表しています.
- このモデルは 積極的なリスク評価を可能にし,心血管疾患を予防するための早期介入戦略を容易にする.
- 複数の機械学習技術を統合することで 臨床的意思決定に より正確で信頼性の高いツールが提供されます
関連する概念動画
01:15Model Approaches for Pharmacokinetic Data: Physiological Models
108
Physiological models in pharmacokinetics are instrumental in understanding the distribution and elimination of drugs within the body. These models describe the drug concentration within target organs, influenced by factors such as drug uptake, tissue volume, and blood flow. Drug uptake is governed by the partition coefficient, which signifies the drug concentration ratio in tissue to that in the blood. The blood flow rate to a specific tissue is expressed as Qt, and the rate of change in tissue...
108
00:59Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis
124
Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
124
01:18Neural Regulation of Blood Pressure
3.4K
The neural regulation of blood pressure involves intricate interactions between the autonomic nervous system (ANS) and cardiovascular system, ensuring adequate perfusion of tissues. This regulation primarily occurs through baroreceptor and chemoreceptor reflexes, involving both short-term and long-term mechanisms.
Baroreceptor Reflex
Baroreceptors, located in the carotid sinuses and aortic arch, detect changes in blood pressure. When blood pressure rises, these stretch-sensitive receptors...
Baroreceptor Reflex
Baroreceptors, located in the carotid sinuses and aortic arch, detect changes in blood pressure. When blood pressure rises, these stretch-sensitive receptors...
3.4K
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
332
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
332
01:06Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
126
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
126
01:14Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches
223
Drug disposition in the body is a complex process and can be studied using two major approaches: the model and the model-independent approaches.
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
223